BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 29635374)

  • 1. Genome-wide determination of on-target and off-target characteristics for RNA-guided DNA methylation by dCas9 methyltransferases.
    Lin L; Liu Y; Xu F; Huang J; Daugaard TF; Petersen TS; Hansen B; Ye L; Zhou Q; Fang F; Yang L; Li S; Fløe L; Jensen KT; Shrock E; Chen F; Yang H; Wang J; Liu X; Xu X; Bolund L; Nielsen AL; Luo Y
    Gigascience; 2018 Mar; 7(3):1-19. PubMed ID: 29635374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein engineering strategies for improving the selective methylation of target CpG sites by a dCas9-directed cytosine methyltransferase in bacteria.
    Xiong T; Rohm D; Workman RE; Roundtree L; Novina CD; Timp W; Ostermeier M
    PLoS One; 2018; 13(12):e0209408. PubMed ID: 30562388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A modular dCas9-SunTag DNMT3A epigenome editing system overcomes pervasive off-target activity of direct fusion dCas9-DNMT3A constructs.
    Pflueger C; Tan D; Swain T; Nguyen T; Pflueger J; Nefzger C; Polo JM; Ford E; Lister R
    Genome Res; 2018 Aug; 28(8):1193-1206. PubMed ID: 29907613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ezh2-dCas9 and KRAB-dCas9 enable engineering of epigenetic memory in a context-dependent manner.
    O'Geen H; Bates SL; Carter SS; Nisson KA; Halmai J; Fink KD; Rhie SK; Farnham PJ; Segal DJ
    Epigenetics Chromatin; 2019 May; 12(1):26. PubMed ID: 31053162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA epigenome editing using CRISPR-Cas SunTag-directed DNMT3A.
    Huang YH; Su J; Lei Y; Brunetti L; Gundry MC; Zhang X; Jeong M; Li W; Goodell MA
    Genome Biol; 2017 Sep; 18(1):176. PubMed ID: 28923089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonistic and synergistic epigenetic modulation using orthologous CRISPR/dCas9-based modular system.
    Josipović G; Tadić V; Klasić M; Zanki V; Bečeheli I; Chung F; Ghantous A; Keser T; Madunić J; Bošković M; Lauc G; Herceg Z; Vojta A; Zoldoš V
    Nucleic Acids Res; 2019 Oct; 47(18):9637-9657. PubMed ID: 31410472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repurposing the CRISPR-Cas9 system for targeted DNA methylation.
    Vojta A; Dobrinić P; Tadić V; Bočkor L; Korać P; Julg B; Klasić M; Zoldoš V
    Nucleic Acids Res; 2016 Jul; 44(12):5615-28. PubMed ID: 26969735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient Targeted DNA Methylation with dCas9-Coupled DNMT3A-DNMT3L Methyltransferase.
    Bashtrykov P; Rajaram N; Jeltsch A
    Methods Mol Biol; 2023; 2577():177-188. PubMed ID: 36173573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locus-Specific Regulation of
    Deng M; Liu Z; Chen B; Cai Y; Wan Y; Wang F
    DNA Cell Biol; 2020 Apr; 39(4):572-578. PubMed ID: 32073884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation-independent long-term epigenetic silencing with dCRISPR/Cas9 fusion proteins.
    Ding L; Schmitt LT; Brux M; Sürün D; Augsburg M; Lansing F; Mircetic J; Theis M; Buchholz F
    Life Sci Alliance; 2022 Jun; 5(6):. PubMed ID: 35288457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzyme-free targeted DNA demethylation using CRISPR-dCas9-based steric hindrance to identify DNA methylation marks causal to altered gene expression.
    Sapozhnikov DM; Szyf M
    Nat Protoc; 2022 Dec; 17(12):2840-2881. PubMed ID: 36207463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversing Mechanoinductive DSP Expression by CRISPR/dCas9-mediated Epigenome Editing.
    Qu J; Zhu L; Zhou Z; Chen P; Liu S; Locy ML; Thannickal VJ; Zhou Y
    Am J Respir Crit Care Med; 2018 Sep; 198(5):599-609. PubMed ID: 29924937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of SNCA Expression by Targeted Editing of DNA Methylation: A Potential Strategy for Precision Therapy in PD.
    Kantor B; Tagliafierro L; Gu J; Zamora ME; Ilich E; Grenier C; Huang ZY; Murphy S; Chiba-Falek O
    Mol Ther; 2018 Nov; 26(11):2638-2649. PubMed ID: 30266652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted DNA methylation in human cells using engineered dCas9-methyltransferases.
    Xiong T; Meister GE; Workman RE; Kato NC; Spellberg MJ; Turker F; Timp W; Ostermeier M; Novina CD
    Sci Rep; 2017 Jul; 7(1):6732. PubMed ID: 28751638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic profiling of DNA methyltransferases reveals a role for DNMT3B in genic methylation.
    Baubec T; Colombo DF; Wirbelauer C; Schmidt J; Burger L; Krebs AR; Akalin A; Schübeler D
    Nature; 2015 Apr; 520(7546):243-7. PubMed ID: 25607372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host Cell Transcriptional Tuning with CRISPR/dCas9 to Mitigate the Effects of Toxin Exposure.
    Metzger D; Miller K; Lyon W; Migliozzi R; Pangburn HA; Saldanha R
    ACS Synth Biol; 2022 Nov; 11(11):3657-3668. PubMed ID: 36318971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site-specific targeting of a light activated dCas9-KillerRed fusion protein generates transient, localized regions of oxidative DNA damage.
    House NCM; Parasuram R; Layer JV; Price BD
    PLoS One; 2020; 15(12):e0237759. PubMed ID: 33332350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CpG sites preferentially methylated by Dnmt3a in vivo.
    Oka M; Rodić N; Graddy J; Chang LJ; Terada N
    J Biol Chem; 2006 Apr; 281(15):9901-8. PubMed ID: 16439359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review on CRISPR/Cas-based epigenetic regulation in plants.
    Jogam P; Sandhya D; Alok A; Peddaboina V; Allini VR; Zhang B
    Int J Biol Macromol; 2022 Oct; 219():1261-1271. PubMed ID: 36057300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted DNA methylation in pericentromeres with genome editing-based artificial DNA methyltransferase.
    Yamazaki T; Hatano Y; Handa T; Kato S; Hoida K; Yamamura R; Fukuyama T; Uematsu T; Kobayashi N; Kimura H; Yamagata K
    PLoS One; 2017; 12(5):e0177764. PubMed ID: 28542388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.